CAS 1107620-67-6: 2H,6H-Pyrano[3,2-b]xanthen-6-one,3,4-dihydro-7,10-dihydroxy-12-methoxy-2,2-dimethyl-
Description:2H,6H-Pyrano[3,2-b]xanthen-6-one, 3,4-dihydro-7,10-dihydroxy-12-methoxy-2,2-dimethyl- is a complex organic compound characterized by its unique fused ring structure, which includes a pyran and xanthenone moiety. This compound typically exhibits properties such as solubility in organic solvents, and its structure suggests potential for various chemical reactivity, including hydrogen bonding and π-π stacking interactions due to the presence of aromatic systems. The hydroxyl groups contribute to its polarity and potential for forming hydrogen bonds, which may enhance its solubility in polar solvents. Additionally, the methoxy and dimethyl groups can influence its electronic properties and steric hindrance, affecting its reactivity and interaction with biological systems. Such compounds are often studied for their potential applications in fields like organic electronics, photochemistry, and medicinal chemistry, where their unique structural features may impart desirable properties for specific applications.
Formula:C19H18O6
- Synonyms:
- GarcinexanthoneA
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Garcinexanthone A REF: IN-DA008YB0CAS: 1107620-67-6 | - - - | To inquire | Tue 22 Apr 25 |
![]() | Garcinexanthone A REF: TM-TN4111CAS: 1107620-67-6 | 98% | To inquire | Mon 21 Apr 25 |
![]() | Garcinexanthone A REF: BP-SBP01317CAS: 1107620-67-6 | 95%~99% | To inquire | Wed 23 Apr 25 |
![]() | garcinexanthone A REF: 3D-FG42690CAS: 1107620-67-6 | Min. 95% | - - - | Discontinued product |

Garcinexanthone A
Ref: TM-TN4111
5mg | 627.00 € | ||
1mL*10mM (DMSO) | 637.00 € |

Garcinexanthone A
Ref: BP-SBP01317
Undefined size | To inquire |

garcinexanthone A
Ref: 3D-FG42690
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
250µg | Discontinued | Request information | |
500µg | Discontinued | Request information |